Tramadol ER 200mg Capsules

Manufacturer TRIGEN LABORATORIES Active Ingredient Tramadol Extended-Release Capsules and Tablets(TRA ma dole) Pronunciation TRA ma dole
WARNING: For all patients taking this drug:This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing.Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life- threatening if not treated.Children:This drug is not approved for use in children. Severe and sometimes deadly breathing problems have happened with tramadol in children. Sometimes, this happened after surgery to remove tonsils or adenoids and in children who were rapid metabolizers of tramadol. Do not give to a child younger than 12 years of age. Do not give to a child younger than 18 years of age who is very overweight, has certain health problems like sleep apnea or other lung or breathing problems, or has had surgery to remove tonsils or adenoids. If your child has been given this drug, ask the doctor about the benefits and risks. @ COMMON USES: It is used to manage pain when daily pain treatment is needed for a long time. It is for use when non-opioid pain drugs do not treat your pain well enough or you cannot take them.
🏷️
Drug Class
Opioid Analgesic
🧬
Pharmacologic Class
Centrally acting synthetic opioid analgesic; Serotonin-norepinephrine reuptake inhibitor (SNRI)
🀰
Pregnancy Category
C
βœ…
FDA Approved
Mar 1995
βš–οΈ
DEA Schedule
Schedule IV

Overview

ℹ️

What is this medicine?

Tramadol ER is an extended-release pain medicine used to treat moderate to moderately severe chronic pain that needs around-the-clock treatment. It works by changing how your brain and nervous system respond to pain, similar to how opioids work, but also by affecting certain brain chemicals.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To use this medication safely and effectively, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions precisely.

Take this medication by mouth only. Do not inject or snort it, as this can cause severe side effects, including breathing difficulties and overdose, which can be fatal.
Swallow the medication whole. Do not chew, break, crush, or dissolve it before swallowing, as this can also cause severe side effects and death.
You can take this medication with or without food. However, some products must be taken consistently, either always with food or always without food. Be sure to understand how to take your specific product in relation to food. If you are unsure, consult your doctor or pharmacist.
Take this medication at the same time every day.
Do not use this medication for rapid pain relief or on an as-needed basis.
If you have not been taking medications like this one, do not use it for pain relief after surgery.
If you have difficulty swallowing, discuss this with your doctor.

Storing and Disposing of Your Medication

Store this medication at room temperature in a dry place, avoiding storage in a bathroom.
Keep this medication in a secure location where children cannot see or reach it, and where others cannot access it. Consider using a locked box or area to ensure safety.
Keep all medications away from pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. Consult your pharmacist for guidance on the best disposal method. You may also have access to drug take-back programs in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember.
If it is close to the time for your next dose, skip the missed dose and resume your regular schedule.
Do not take two doses at the same time or take extra doses.
πŸ’‘

Lifestyle & Tips

  • Take exactly as prescribed; do not take more or less than directed.
  • Swallow the capsule whole; do not crush, chew, or break it, as this can lead to a rapid release of the drug and a potentially fatal overdose.
  • Do not drink alcohol while taking tramadol, as it can increase the risk of serious side effects like severe drowsiness and breathing problems.
  • Avoid driving or operating heavy machinery until you know how tramadol affects you, as it can cause dizziness and drowsiness.
  • Store tramadol securely away from children and pets, as accidental ingestion can be fatal.
  • Discuss all other medications, including over-the-counter drugs, supplements, and herbal products, with your doctor to avoid dangerous interactions.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Initial: 100 mg once daily. Titrate by 100 mg increments every 5 days to achieve balance between efficacy and tolerability.
Dose Range: 100 - 300 mg

Condition-Specific Dosing:

chronic_pain: For management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment for an extended period of time.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established in pediatric patients <18 years of age)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed for CrCl > 30 mL/min.
Moderate: CrCl < 30 mL/min: Not recommended for Tramadol ER.
Severe: CrCl < 30 mL/min: Not recommended for Tramadol ER.
Dialysis: Not recommended for Tramadol ER due to extended-release formulation and prolonged half-life in renal impairment.

Hepatic Impairment:

Mild: No specific adjustment for mild impairment.
Moderate: Not recommended for Tramadol ER in patients with moderate hepatic impairment (Child-Pugh Class B).
Severe: Not recommended for Tramadol ER in patients with severe hepatic impairment (Child-Pugh Class C).

Pharmacology

πŸ”¬

Mechanism of Action

Tramadol is a centrally acting synthetic opioid analgesic. Its analgesic effect is due to both binding of the parent drug and its active metabolite, O-desmethyltramadol (M1), to mu-opioid receptors and to weak inhibition of norepinephrine and serotonin reuptake. M1 has a significantly higher affinity for mu-opioid receptors than tramadol.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 75% (oral)
Tmax: Tramadol ER: 12 hours (parent drug), 14 hours (M1)
FoodEffect: Food does not significantly affect the rate or extent of absorption of Tramadol ER.

Distribution:

Vd: 2.6-3.0 L/kg
ProteinBinding: Approximately 20% (tramadol), 30% (M1)
CnssPenetration: Yes

Elimination:

HalfLife: Tramadol: 6.3 hours; M1: 7.4 hours (after single dose of ER)
Clearance: Not available (primarily renal excretion of metabolites)
ExcretionRoute: Renal (approximately 90% of dose excreted renally as unchanged drug and metabolites)
Unchanged: Approximately 30% (tramadol), 6% (M1)
⏱️

Pharmacodynamics

OnsetOfAction: Not applicable for ER formulation (designed for sustained release)
PeakEffect: Not applicable for ER formulation (designed for sustained release)
DurationOfAction: 24 hours

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE; RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P450 2D6 ULTRA-RAPID METABOLISM; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS.

Addiction, Abuse, and Misuse: Tramadol exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing Tramadol, and monitor all patients receiving Tramadol for the development of these behaviors or conditions.

Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur with use of Tramadol. Monitor for respiratory depression, especially during initiation of Tramadol or following a dose increase.

Accidental Ingestion: Accidental ingestion of even one dose of Tramadol, especially by children, can result in a fatal overdose of tramadol.

Neonatal Opioid Withdrawal Syndrome: Prolonged use of Tramadol during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.

CYP2D6 Ultra-Rapid Metabolism: Life-threatening respiratory depression and death have occurred in children who received tramadol and became ultra-rapid metabolizers of tramadol due to a CYP2D6 polymorphism. Tramadol is contraindicated in children younger than 12 years of age and in children younger than 18 years of age following tonsillectomy and/or adenoidectomy. Avoid the use of Tramadol in adolescents 12 to 18 years of age who have other risk factors for respiratory depression unless the benefits outweigh the risks.

Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants: Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Rarely, allergic reactions can be fatal.
Signs of depression, suicidal thoughts, or mood changes, such as:
+ Emotional ups and downs
+ Abnormal thinking
+ Anxiety
+ Lack of interest in life
Signs of low sodium levels, including:
+ Headache
+ Trouble focusing
+ Memory problems
+ Feeling confused
+ Weakness
+ Seizures
+ Changes in balance
Severe dizziness or fainting
Feeling confused
Seizures
Chest pain or pressure, or a rapid heartbeat
Difficulty urinating
Frequent urination
Breathing difficulties, such as:
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Changes in vision
Severe constipation or stomach pain, which may indicate a severe bowel problem
Serotonin syndrome, a potentially life-threatening condition, may occur, especially when taking certain other medications. Seek medical help immediately if you experience:
+ Agitation
+ Changes in balance
+ Confusion
+ Hallucinations
+ Fever
+ Rapid or abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea, nausea, or vomiting
+ Severe headache
Stevens-Johnson syndrome/toxic epidermal necrolysis, a severe skin reaction, may occur. Seek medical help immediately if you notice:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in your mouth, throat, nose, or eyes

Other Possible Side Effects

Most people experience few or no side effects. However, if you notice any of the following symptoms, contact your doctor or seek medical attention if they bother you or persist:

Feeling dizzy, sleepy, tired, or weak
Constipation, diarrhea, nausea, or vomiting
Dry mouth
Headache
Itching
Trouble sleeping
Flushing
* Excessive sweating

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow, shallow, or difficult breathing (signs of respiratory depression)
  • Extreme drowsiness, dizziness, or feeling faint
  • Confusion, agitation, hallucinations, rapid heart rate, fever, sweating, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea (signs of serotonin syndrome)
  • Seizures
  • Severe constipation or difficulty urinating
  • Swelling of the face, lips, tongue, or throat; difficulty swallowing or breathing (signs of allergic reaction)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction and its symptoms.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
Kidney or liver disease
A history of suicidal thoughts or previous substance abuse or dependence, including alcohol
If your doctor has informed you that you are a rapid metabolizer of certain medications
Recent consumption of large amounts of alcohol or use of medications that may impair your actions, such as phenobarbital or pain relievers like oxycodone
Current use of carbamazepine
Use of another medication containing the same active ingredient
Concurrent use of the following medications:
+ Buprenorphine
+ Butorphanol
+ Linezolid
+ Methylene blue
+ Nalbuphine
+ Pentazocine
Use of certain medications for depression or Parkinson's disease within the last 14 days, including:
+ Isocarboxazid
+ Phenelzine
+ Tranylcypromine
+ Selegiline
+ Rasagiline (note: this may lead to severely high blood pressure)
* If you are breastfeeding, as you should not breastfeed while taking this medication

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems. Ensure that it is safe to take this medication with your other medications and health conditions before starting, stopping, or changing the dose of any medication. Always consult your doctor before making any changes.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and exercise caution when climbing stairs.

Dosage and Administration
Do not exceed the dosage prescribed by your doctor. Taking more than the recommended amount may increase the risk of severe side effects. Additionally, do not take this medication with other strong pain medications or use a pain patch without consulting your doctor first.

Monitoring Pain and Side Effects
If your pain worsens, you experience increased sensitivity to pain, or you develop new pain after taking this medication, contact your doctor immediately. Do not take more than the prescribed amount.

Seizure Risk
This medication may increase the risk of seizures, particularly in individuals with certain health conditions, those taking specific medications, or those who consume excessive alcohol. Discuss your risk of seizures with your doctor.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, requiring higher doses to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed amount.

Low Blood Sugar
This medication may cause low blood sugar, which can be severe enough to require hospitalization. If you experience symptoms such as dizziness, headache, fatigue, shaking, rapid heartbeat, confusion, hunger, or sweating, contact your doctor immediately.

Dependence and Withdrawal
Long-term or regular use of opioid medications like this one may lead to dependence. Suddenly lowering the dose or stopping the medication may increase the risk of withdrawal or other severe problems. Consult your doctor before reducing the dose or discontinuing the medication, and follow their instructions. Report any increased pain, mood changes, suicidal thoughts, or other adverse effects to your doctor.

Interactions with Alcohol
Do not consume alcohol or use products containing alcohol while taking this medication, as this may lead to unsafe and potentially fatal effects.

Hormonal Effects
Long-term use of opioid medications may cause a decrease in sex hormone levels. If you experience a decreased interest in sex, fertility problems, irregular menstrual periods, or ejaculation problems, contact your doctor.

Adrenal Gland Problems
Taking an opioid medication like this one may lead to a rare but severe adrenal gland disorder. If you experience extreme fatigue, weakness, fainting, severe dizziness, nausea, vomiting, or decreased appetite, contact your doctor immediately.

Special Considerations for Older Adults
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Respiratory depression (slowed or stopped breathing)
  • Extreme drowsiness progressing to stupor or coma
  • Pinpoint pupils
  • Skeletal muscle flaccidity
  • Cold, clammy skin
  • Bradycardia (slow heart rate)
  • Hypotension (low blood pressure)
  • Circulatory collapse
  • Cardiac arrest
  • Death
  • Seizures (can occur with or without other opioid overdose symptoms)

What to Do:

Call 911 immediately. Administer naloxone if available and trained to do so. Seek emergency medical attention. Call 1-800-222-1222 (Poison Control Center).

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of MAOI use (risk of serotonin syndrome, seizures)
  • Patients with significant respiratory depression
  • Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment
  • Known or suspected paralytic ileus
  • Hypersensitivity to tramadol or any component of the formulation
πŸ”΄

Major Interactions

  • Benzodiazepines and other CNS depressants (e.g., other opioids, alcohol, sedatives, hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, phenothiazines): Increased risk of profound sedation, respiratory depression, coma, and death.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, linezolid, St. John's Wort): Risk of serotonin syndrome.
  • CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine): May increase tramadol exposure and decrease M1 exposure, potentially reducing analgesic effect and increasing risk of adverse events from tramadol.
  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, ritonavir): May increase tramadol exposure, leading to increased risk of adverse events.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): May decrease tramadol exposure and increase M1 exposure, potentially reducing analgesic effect and increasing risk of M1-related adverse events.
  • Carbamazepine: Significantly reduces tramadol plasma concentrations, reducing analgesic effect. Concomitant use is not recommended.
  • Warfarin: Increased INR and ecchymoses have been reported; monitor prothrombin time/INR.
🟑

Moderate Interactions

  • Diuretics: Opioids may reduce the efficacy of diuretics by inducing the release of antidiuretic hormone.
  • Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pain assessment (intensity, location, quality)

Rationale: To establish baseline pain level and guide initial dosing.

Timing: Prior to initiation of therapy

Respiratory rate and depth

Rationale: To assess baseline respiratory function, especially in patients with pre-existing respiratory compromise.

Timing: Prior to initiation of therapy

Mental status (alertness, orientation)

Rationale: To assess baseline neurological function and identify risk for CNS depression.

Timing: Prior to initiation of therapy

Concomitant medications review

Rationale: To identify potential drug-drug interactions, especially with CNS depressants or serotonergic drugs.

Timing: Prior to initiation of therapy

Renal and hepatic function tests (CrCl, LFTs)

Rationale: To assess organ function and determine need for dose adjustment or contraindication.

Timing: Prior to initiation of therapy

πŸ“Š

Routine Monitoring

Pain assessment

Frequency: Regularly, as clinically indicated (e.g., weekly during titration, then monthly/quarterly)

Target: Acceptable pain control with minimal side effects

Action Threshold: Inadequate pain control or intolerable side effects warrant dose adjustment or re-evaluation of therapy.

Signs of respiratory depression (rate, depth, oxygen saturation)

Frequency: Periodically, especially during initiation and dose titration, or with concomitant CNS depressants.

Target: Normal respiratory rate (12-20 breaths/min), SpO2 > 92%

Action Threshold: Respiratory rate < 10 breaths/min, shallow breathing, cyanosis, or SpO2 < 90% requires immediate intervention.

Signs of CNS depression (sedation, somnolence, confusion)

Frequency: Periodically, especially during initiation and dose titration.

Target: Alert and oriented

Action Threshold: Excessive sedation, difficulty arousing, or confusion warrants dose reduction or discontinuation.

Signs of serotonin syndrome (agitation, hallucinations, tachycardia, hyperthermia, hyperreflexia, incoordination, nausea, vomiting, diarrhea)

Frequency: Monitor closely, especially with concomitant serotonergic drugs.

Target: Absence of symptoms

Action Threshold: Presence of symptoms requires immediate discontinuation of tramadol and supportive care.

Signs of opioid abuse, misuse, or addiction

Frequency: Regularly, as part of risk mitigation strategy.

Target: Adherence to prescribed regimen

Action Threshold: Aberrant drug-related behaviors warrant re-evaluation of therapy and potential referral to addiction specialist.

πŸ‘οΈ

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing)
  • Excessive sedation or somnolence
  • Dizziness, lightheadedness
  • Nausea, vomiting, constipation
  • Seizures
  • Symptoms of serotonin syndrome (agitation, confusion, rapid heart rate, fever, sweating, muscle rigidity, tremors, twitching, loss of coordination, severe diarrhea)
  • Symptoms of opioid withdrawal (in patients physically dependent who abruptly discontinue)

Special Patient Groups

🀰

Pregnancy

Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome (NOWS), which may be life-threatening if not recognized and treated. Use only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for congenital malformations with opioid exposure. Risk of NOWS if continued.
Second Trimester: Risk of NOWS if prolonged use.
Third Trimester: High risk of NOWS with prolonged use. May cause respiratory depression in the neonate if used near delivery.
🀱

Lactation

Tramadol and its active metabolite (M1) are present in breast milk. Infants exposed to tramadol through breast milk are at risk of serious adverse reactions, including excess sedation and respiratory depression. Breastfeeding is not recommended during treatment with tramadol.

Infant Risk: Risk of excess sedation, respiratory depression, and potentially death. Monitor infants for increased sleepiness, difficulty breathing, or limpness. If these symptoms occur, seek immediate medical attention.
πŸ‘Ά

Pediatric Use

Contraindicated in children younger than 12 years of age. Contraindicated in children younger than 18 years of age following tonsillectomy and/or adenoidectomy. Avoid use in adolescents 12 to 18 years of age who have other risk factors for respiratory depression unless benefits outweigh risks. Safety and efficacy not established for chronic pain in pediatric patients.

πŸ‘΄

Geriatric Use

Use with caution in elderly patients (β‰₯65 years) due to increased risk of respiratory depression, falls, and CNS effects. Start with lower doses and titrate slowly. Monitor renal function, as clearance may be reduced.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Tramadol ER is for chronic, around-the-clock pain, not for as-needed or acute pain.
  • Do not crush, chew, or dissolve ER capsules; this can lead to rapid release and fatal overdose.
  • Be aware of the Black Box Warnings, especially regarding addiction, respiratory depression, and concomitant use with CNS depressants.
  • Monitor for serotonin syndrome, especially if co-administered with other serotonergic agents.
  • Patients who are CYP2D6 ultra-rapid metabolizers may experience increased M1 levels, leading to increased opioid effects and respiratory depression.
  • Titrate dose slowly to minimize adverse effects and optimize pain control.
  • Consider a bowel regimen to prevent opioid-induced constipation.
πŸ”„

Alternative Therapies

  • Other extended-release opioid analgesics (e.g., morphine ER, oxycodone ER, hydromorphone ER)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for less severe pain or as adjuncts
  • Adjuvant analgesics (e.g., gabapentin, pregabalin, duloxetine, tricyclic antidepressants) for neuropathic pain or chronic pain syndromes
  • Interventional pain management techniques
  • Physical therapy, occupational therapy
  • Cognitive behavioral therapy (CBT)
πŸ’°

Cost & Coverage

Average Cost: Varies widely per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 1-3 (depending on plan and generic vs. brand)
πŸ“š

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a patient fact sheet that provides crucial information. It is vital to read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider.

In the event of an overdose, a medication called naloxone can be administered to help treat the condition. Discuss obtaining and using naloxone with your doctor or pharmacist. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide detailed information about the overdose, including the substance taken, the amount, and the time it occurred.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care immediately. When reporting the incident, be prepared to disclose the substance involved, the quantity taken, and the time of the incident to ensure timely and effective treatment.